Abiopharma

🔍 WIINBERG ULF (Executive)

Company: MiNK Therapeutics, Inc. (INKT)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Acquired 1,279 shares of Common Stock at $10.95 per share (Direct)
  Date: 2026-09-01 | Code: A | equity_swap_involved: false | shares_owned_after: 23,929.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-09-01 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 27,830.00 | Footnotes: F2, F2

Footnotes:

• F1: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.
• F2: Shares are held in an irrevocable trust for the benefit of Mr. Wiinberg's family.